quaternary ammonium polyethylenimine |
– |
– |
S. mutans and L. casei: >40% reduction;S. mutans monospecies biofilm: >60% reduction |
orthodontic brackets |
[83] |
TMC-Lip-DOX NPs |
a diameter of around 107.6 nm |
– |
bacterial biofilm: a small number of free bacteria;in vivo: the bacterial plaque decreased |
good potential for use in the treatment of periodontal and other inflammatory diseases |
[84] |
catechol-functionalized chitosan and Ag NPs |
homogenous esterification reaction |
– |
E. coli, S. aureus: adhered bacterial cell; E. coil: dead: 32.2%;S. aureus: dead: 14.3% |
coatings for practical biomedical applications |
[88] |
Curcuma xanthorrhiza oil |
– |
sonication |
S. mutans biofilm: 10 min: the lowest value of 5.72 log10 CFU mL−1 compared with distilled water (7.83 log10 CFU mL−1) and Listerine (7.52 log10 CFU mL−1), |
nanoemulsion–based mouthwash |
[89] |
N-CUR@ICG- Met |
a uniform shape |
under ultrasonic conditions |
E. faecalis biofilm: aPDT: statistically decrease; aPDT/LED < aPDT/diode |
a synergistic advantage with photosensitivity |
[90] |
nCUR- ABBL |
length: around 200 nm; width: 50–100 nm |
– |
S. mutans biofilm: 5%: 60 d: decreased 40% |
an excellent ABBL additive in aPDT producer |
[91] |
chlorhexidine |
particle diameter: 140 nm; pore: 2.5 nm |
CHX swell and assemble to nanoparticles |
S. mutans: MIC: 19.5 mg/mL; MBC: 312.5 mg/mL;E. faecalis: MIC: 156 mg/mL; MBC: 1250 mg/mL |
a novel and promising anti-biofilm agent |
[92] |
SB and pure chlorhexidine |
diameter: 140 nm; pore: 2.5 nm; volume: 1.0 cm3/g |
SB was swelled and loaded into mesoporous silica nanoparticle |
S. mutans; S. sobrinus; F. nucleatum, A. actinomycetemcomitans: MIC: lower than 50 μg/mL;E. faecalis: MIC: 200 μg/mL; |
potential clinical usage |
[93] |
nano cinnamon powder |
– |
mechanical attrition method |
S. mutans: inhibition zone: 3%: 25 mm |
orthodontic |
[94] |
Cinnamon modified TiO2 NPs |
10.5 nm |
hydrodistillation |
P. aeruginosa: large inhibition zone |
potential biological applications |
[95] |